SLC39A13 Knockout HCT 116 Cell Line
Cat.No.:
EDC07723
Species:
Human
Cell Name:
HCT 116
Gene:
SLC39A13
Gene ID:
91252
Size:
1×10⁶cells
SLC39A13 Knockout HCT116 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07723 |
|---|---|
| Product Name | SLC39A13 Knockout HCT116 Cell Line |
| Species | Human |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Gene ID | |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | SLC39A13 |
| Gene Synonyms | EDSSPD3|LZT-Hs9|SCDEDS|ZIP13 |
| Summary |
This gene encodes a member of the LIV-1 subfamily of the ZIP transporter family. The encoded transmembrane protein functions as a zinc transporter. Mutations in this gene have been associated with the spondylocheiro dysplastic form of Ehlers-Danlos syndrome. Alternate transcript variants have been found for this gene. [provided by RefSeq, Jan 2016]
|
| Associated Diseases | Colorectal Carcinoma |
| Digestion Time | 3 min |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 90% FBS/complete culture medium+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC39A13 function, SLC39A13 Knockout HCT 116 Cell Line or SLC39A13 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC39A13 (ZIP13)'s role as a Golgi/ER-localized zinc transporter or modeling spondylocheirodysplastic Ehlers-Danlos syndrome (SCD-EDS). The Knockout line is the standard tool for asking whether ZIP13 is required for zinc release from intracellular compartments — ZIP13 functions in the Golgi/ER rather than at the plasma membrane, distinguishing it from many other ZIP family members. Overexpression is useful for studying ZIP13's role in secretory pathway function and connective tissue biology.
For ZIP13 research, the EDITGENE Knockout in HCT 116 enables study of intracellular zinc trafficking and ER/Golgi zinc-dependent processes. SLC39A13 mutations cause SCD-EDS, characterized by connective tissue abnormalities — disease variant rescue enables genotype-function studies in a controlled background. Rescue with wild-type or transport-deficient ZIP13 is the standard specificity control.
What are the application scenarios for this model?
Primary applications:
• Intracellular zinc trafficking: subcellular zinc distribution analysis using FluoZin-3 imaging and organelle-targeted zinc sensors.
• Golgi/ER zinc function: analysis of zinc-dependent secretory pathway processes and collagen processing.
• SCD-EDS modeling: rescue with patient-derived SLC39A13 mutations for connective tissue disease genotype-function correlation.
• ZIP family compensation: ZIP7 (also Golgi-localized) expression analysis to interpret ZIP13-specific phenotypes.
EDITGENE recommends this model for researchers investigating intracellular zinc transport, connective tissue biology, and SCD-EDS disease mechanisms.
Is this SLC39A13 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. ZIP13 rescue experiments require attention to intracellular targeting:
• Construct design: use a codon-modified SLC39A13 sequence with a small C-terminal tag (FLAG, HA). ZIP13 has 8 transmembrane domains with Golgi/ER targeting determinants.
• Intracellular localization validation: confirm Golgi/ER localization of exogenous ZIP13 by GM130 or KDEL co-staining before functional assays.
• SCD-EDS mutation rescue: patient-derived SLC39A13 mutations (e.g., G64D, frameshift mutations) enable connective tissue disease modeling.
• Functional readout: rescue should restore intracellular zinc trafficking and zinc-dependent collagen processing.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download